ABSTRACT The analysis of left ventricular end-systolic pressure-volume relationships in human beings has been hindered by the lack of a practical method of serial volume assessment and by an imprecise definition of end-systole. Modifications of the end-systolic relationship that have been used to circumvent these problems have included the use of single-point end-systolic pressure-volume ratios, the use of peak systolic pressure/minimum ventricular volume points for end-systolic points, and the use of end-ejection as a marker for end-systole. To assess the correlation between the parameters generated by these modifications with the slope (Emax) and volume intercept (V0) 
generated by these modifications with the slope (Emax) and volume intercept (V0) of the end-systolic line as defined by Sagawa's model of time-varying elastance, simultaneous measurement of left ventricular pressure and gated radionuclide volume was made in 26 patients under various loading conditions and pressure-volume diagrams were constructed for each loading condition from 32 simultaneous pressurevolume coordinates. Two pressure-volume diagrams were recorded in 14 patients and three pressurevolume diagrams were recorded in 12 patients. Em.x and VO were determined in all patients from the slope and volume intercept of the isochronic pressure-volume line with the maximum time-varying elastance as described by Sagawa's model and were designated true Emax and true VO, respectively.
True Ema was subsequently correlated with three estimates of Emax computed from a single-point endsystolic ratio (r = .76, SEE = 1.53, p < .001), from peak systolic pressure/minimum systolic volume points (r = .87, SEE = 0.67, p < .001), and from end-ejection pressure-volume points marked by peak negative dP/dt (r = .91, SEE = 0.57, p < .001). It is concluded that the parameters Emax and VO of a time-varying elastance model of the end-systolic pressure-volume relationship can be constructed for man with the use of simultaneous left ventricular pressure measurements and gated radionuclide ventriculography, and that true Emax calculated by this method is reasonably approximated by singlepoint pressure-volume ratios and peak systolic and end-ejection measurements. Circulation 74, No. 1, 97-104, 1986. CONSIDERABLE EVIDENCE from both animal and human studies has suggested that the end-systolic pressure-volume relationship is linear over a physiologic range of loading conditions and is a sensitive indicator of left ventricular contractile function.1 As originally described, 1 2' this relationship may be derived from a model of time-varying elastance, as described by the equation E(t) = P(t)/ (V(t) -Vofi)) where E = elastance; t = time; P = instantaneous pressure; V = instantaneous volume; VO = volume intercept of the end-systolic line. According to this model, the slope of the regression line connecting isochronic pressure-volume coordinates from multiple pressure-volume loops over a range of loading conditions is represented by E or elastance, and increases progressively throughout isovolumetric contraction and left ventricular ejection, and then subsequently decreases during isovolumetric relaxation. The maximum elastance that is achieved, Emax5 represents the slope of the end-systolic line, and has been shown to correlate well with measures of basal contractility and to be sensitive to inotropic modulation.
In spite of the theoretical appeal of end-systolic A second major difficulty has been the precise identification of end-systole. Sagawa has defined end-systole as the point at which the active contractile process has reached a maximum and has identified this point as the time of maximum elastance. However, many clinical investigators have substituted end-ejection for endsystole and used either the aortic pressure dicrotic notch or peak negative dP/dt to determine end-systolic pressure-volume data points.4' 6-7, 13 Still other investigators have assumed no significant difference between peak and end-systolic pressure and have substituted peak-systolic pressure/minimum ventricular volume for end-systolic pressure-volume plots.14, 15 Although there have been multiple reports on the practical utility of the contractile indexes derived from modifications of the end-systolic pressure-volume relationship," there has been no study examining the relationship of these indexes and true Emax as defined by the Analysis. For each mLAO scan that was obtained, a left ventricular count rate (volume) vs time curve was obtained with an operator-drawn, fixed left ventricular region of interest and computer-generated background regions of interest. Background was assumed to be constant both spatially and temporally. The operator used the end-diastolic image to identify the septal border of the ventricle and the stroke volume image to identify the atrioventricular and free wall borders of the heart. In patients with severe left ventricular dysfunction, the end-diastolic image was used to confirm the boundaries of the free wall of the ventricle.
Since multiple left ventricular volume-time curves were obtained in each patient, the relative change in end-diastolic volume between studies was determined by correcting the enddiastolic counts in each curve for acquistion time, physical decay, and biological clearance. Acquisition time for each end-CIRCULATIONdiastolic frame was calculated by multiplying the frame duration (RR interval/number of frames) by the number of cardiac cycles collected. Loss of counts due to physical decay was calculated by checking the time at which each study was acquired. Biological clearance of the tracer was calculated by measuring, in a well counter, the changes in the counts in a 100 ,ul sample of blood obtained at the midpoint of each study.
A square wave that indicated the time at which the gamma camera's computer system detected the patient's R wave on electrocardiogram was output to the Electronics for Medicine recorder to synchronize the radionuclide volumes with the left ventricular pressure tracings (see below).
Changes in left ventricular loading conditions. In all patients, changes in left ventricular loading conditions were effected by pharmacologic intervention. All patients were either on 0-blockers or pretreated with 1 mg of intravenous atropine to avoid changes in heart rate with preload and/or afterload manipulation. Before any change in loading conditions, a mLAO scan was obtained in each patient with simultaneous recording of left ventricular pressure at a rapid paper speed midway through the scan. Subsequently, 18 patients received intravenous nitroglycerin, five received intravenous nitroprusside, and three received intravenous phenylephrine. Nitroglycerin was begun at 25 gug/ min, nitroprusside was begun at 3 ,ug/min, and phenylephrine was begun at 10 ,ug/min. Increasing doses of the medications were administered until an approximate 20 mm Hg decrease in systolic blood pressure had been achieved with nitroglycerin or nitroprusside, or a similiar increase in systolic blood pressure had been achieved with phenylephrine. When a steady state had been achieved, a repeat mLAO scan was obtained with repeat measurement of left ventricular pressure.
A further change in loading conditions was effected in four patients receiving nitroglycerin, seven receiving nitroprusside, and one patient receiving phenylephrine with increases in doses of these medications to achieve an additional 20 mm Hg decrease in systolic blood pressure with nitroglycerin or nitroprusside, and an additional 20 mm Hg increase in blood pressure with phenylephrine. When a steady state had again been achieved, an mLAO scan and left ventricular pressure were again obtained.
Generation of pressure-volume diagrams. Pressure-volume diagrams were constructed for each patient by the method illustrated in figure 1 at baseline and after changes in left ventricular loading conditions. First, the time-activity curve obtained from each mLAO scan was digitized by a Tektronix 4956 computer into 32 volume points. Second, at least six left ventricular pressures tracings obtained midway through the mLAO scan were digitized and averaged into 32 pressure points. Finally, the time-activity volume points and the average left ventricular pressure points were synchronized to end-diastole and pressure-volume diagrams were then plotted from 32 simultaneous pressure-volume coordinates throughout the cardiac cycle. Absolute volumes were assigned to each patient's baseline pressure-volume diagrams by assigning the angiographically determined end-diastolic volume to the loop. Absolute volumes for subsequent pressure-volume diagrams were determined on the basis of relative changes in end-diastolic counts and radionuclide ejection fraction.
Two pressure-volume diagrams were obtained from 14 patients who were examined under two different loading conditions, and three diagrams were constructed for 12 patients who were examined under three different loading conditions. In terms of peak-systolic models, a number of investigators have noted that potentially wide differences exist between peak-systolic and end-systolic pressure. The difference seems to be most pronounced in patients with low systemic vascular resistance. 26 In spite of the theoretical objections enumerated above, in the present study we have found that all three of these modifications reasonably approximate true Potential utility of radionuclide end-systolic pressure-volume relationships. The theoretical appeal of end-systolic pressure-volume contractile indexes lies in the fact that these indexes are load independent and can presumably be used to assess basal contractility and inotropic modulation. Use of these indexes could potentially improve our assessment of left ventricular pump function in a wide variety of pathophysiologic states. Until recently, however, derivation of these indexes has been difficult. Angiographic methods are hindered by the limited number of cardiac cycles that can be analyzed, a high incidence of ventricular arrhythmias, the presence of regional wall motion abnormalities that make geometric assumptions for volume calculations inaccurate, the effect of iodinated contrast on ventricular function, and the risk to the patient from multiple contrast injections. 30 
